...
首页> 外文期刊>Cell death & disease. >VPS33B interacts with NESG1 to modulate EGFR/PI3K/AKT/c-Myc/P53/miR-133a-3p signaling and induce 5-fluorouracil sensitivity in nasopharyngeal carcinoma
【24h】

VPS33B interacts with NESG1 to modulate EGFR/PI3K/AKT/c-Myc/P53/miR-133a-3p signaling and induce 5-fluorouracil sensitivity in nasopharyngeal carcinoma

机译:VPS33B与NESG1相互作用以调制EGFR / PI3K / AKT / C-MYC / P53 / MIR-133A-3P信号,并在鼻咽癌中诱导5-氟尿嘧啶敏感性

获取原文
           

摘要

The vacuolar protein sorting 33B (VPS33B) was rarely reported in malignant tumors. In this research, we demonstrated that overexpression of VPS33B inhibited proliferation and chemoresistance to fluorouracil (5-FU) in nasopharyngeal carcinoma (NPC) in vivo and in vitro. Mechanistic analysis confirmed that overexpression of VPS33B modulated EGFR/PI3K/AKT/c-Myc/P53 signaling to arrest the cell cycle at G1/S phase. In addition, miR-133a-3p, a tumor-suppressive miRNA, was induced by P53 and directly targeted the EGFR/PI3K/AKT/c-Myc/P53 signaling and thus formed a negative feedback loop. Furthermore, another tumor suppressor, NESG1, interacted with VPS33B by colocalizing in the cytoplasm. The knockdown of NESG1 reversed the inhibitory effects of the overexpression of VPS33B in NPC cells by downregulating the PI3K/AKT/c-Jun-mediated transcription repression. Surprisingly, VPS33B was downregulated in the nicotine-treated and LMP-1-overexpressing NPC cells by targeting PI3K/AKT/c-Jun-mediated signaling. In addition, patients with higher VPS33B expression had a longer overall survival. Our study is the first to demonstrate that VPS33B is negatively regulated by LMP-1 and nicotine and thus suppresses the proliferation of NPC cells by interacting with NESG1 to regulate EGFR/PI3K/AKT/c-Myc/P53/miR-133a-3p signaling in NPC cells.
机译:在恶性肿瘤中很少报道真空蛋白质分选33b(VPS33b)。在这项研究中,我们证明VPS33B的过度表达抑制在体内和体外鼻咽癌(NPC)中的氟尿嘧啶(5-FU)的增殖和化学抑制剂。机械分析证实,VPS33B的过表达调制EGFR / PI3K / AKT / C-MYC / P53信号传导以在G1 / S期间捕获细胞周期。另外,MiR-133A-3P,肿瘤抑制miRNA被P53诱导,并直接靶向EGFR / PI3K / AKT / C-MYC / P53信号传导,并因此形成负反馈回路。此外,通过在细胞质中的分致化,另一种肿瘤抑制器NESG1与VPS33B相互作用。 NESG1的敲低通过下调PI3K / AKT / C-Jun介导的转录抑制来反转VPS33b过表达vps33b抑制作用。令人惊讶的是,通过靶向PI3K / AKT / C-Jun介导的信号传导,VPS33B在尼古丁处理和LMP-1过表达NPC细胞中下调。此外,VPS33B表达较高的患者的总体存活率较长。我们的研究是第一个证明VPS33B通过LMP-1和尼古丁负调节,因此通过与NESG1相互作用来调节EGFR / PI3K / AKT / C-MYC / P53 / MIR-133A-3P信号传导来抑制NPC细胞的增殖在NPC细胞中。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号